Suvretta Capital Management’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-400,000
Closed -$3.98M – 120
2021
Q3
$3.98M Hold
400,000
– – 0.07% 84
2021
Q2
$3.99M Hold
400,000
– – 0.06% 94
2021
Q1
$3.98M Buy
+400,000
New +$4.14M 0.06% 86

Other funds holding PRDS

Suvretta Capital Management's PRDS Position: Q4 2021 in Review

Suvretta Capital Management sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 400,000 shares — an estimated $3.98M sold.

Suvretta Capital Management first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $3.99M in Q2 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • Suvretta Capital Management reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 400,000 Pardes Biosciences shares in Q4 2021, an estimated $3.98M.
  • Suvretta Capital Management first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
  • Suvretta Capital Management's Pardes Biosciences position peaked at $3.99M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.